SULFASALAZINE
Generic: SULFASALAZINE
Rising Pharma HoldingsManufacturer
ORALRoute
SULFASALAZINEActive Substance
2025-11-04Original Approval
SULFASALAZINE is FDA application ANDA219046, sponsored by RISING. Any recalls listed below come from FDA drug enforcement reports, and reaction counts are the number of FAERS adverse event reports that mention the drug and that reaction; a report does not prove the drug caused it.
Top Reported Reactions
1
DRUG INEFFECTIVE
29,012 reports
2
RHEUMATOID ARTHRITIS
19,334 reports
3
PAIN
15,763 reports
4
DRUG INTOLERANCE
13,735 reports
5
ARTHRALGIA
13,258 reports
6
FATIGUE
13,189 reports
7
JOINT SWELLING
12,672 reports
8
OFF LABEL USE
11,014 reports
9
RASH
10,834 reports
10
ABDOMINAL DISCOMFORT
9,998 reports